Evidence map›Paper›PMID 40533820›Full record

ReviewJournal of translational medicine2025

An In-depth overview of artificial intelligence (AI) tool utilization across diverse phases of organ transplantation.

Shiva Arjmandmazidi, Hamid Reza Heidari, Tohid Ghasemnejad, Zeinab Mori, Leila Molavi, Amir Meraji, Shadi Kaghazchi, Elnaz Mehdizadeh Aghdam, Soheila Montazersaheb

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiva ArjmandmazidiMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hamid Reza HeidariMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tohid GhasemnejadUNSW BioMedical Machine Learning Lab (BML), School of Biomedical Engineering, UNSW Sydney, Sydney, NSW, 2052, Australia.
Zeinab MoriMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Leila MolaviMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amir MerajiMolecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shadi KaghazchiWomen's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Elnaz Mehdizadeh Aghdam *Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mehdizadehe@tbzmed.ac.ir.
Soheila Montazersaheb *Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. smontazersaheb@gmail.com.ORCID 0000-0001-5010-7293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) offers a revolutionary approach to improve decision-making in medicine through the use of advanced computational tools. Its ability to analyze large and complex datasets enables a thorough evaluation of multiple factors, leading to a deeper understanding of medical procedures. Numerous studies have demonstrated that AI has made significant advancements in areas such as organ allocation, donor-recipient matching, and immunosuppression protocols in organ transplantation. The transplantation process consists of three key stages: pre-transplant evaluation, the surgical procedure, and post-transplant management. AI can enhance all three stages by analyzing and integrating data from histopathological reports, lab results, radiological features, and patient demographics to aid in matching donors and recipients. Additionally, AI supports robotic-assisted surgery and optimizes post-transplant regimens while evaluating complications. Various researches have utilized machine learning (ML) to predict medication bioavailability immediately after transplantation and assess the risk of post-transplant complications based on factors like genetic phenotypes, age, gender, and body mass index. This review aims to gather information on AI applications across various stages of organ transplantation and elaborate the strategies and tools relevant to these processes.

Indexed as

Artificial IntelligenceOrgan TransplantationHumansMachine LearningArtificial intelligenceDeep learningEnsemble methodsMachine learningNeural networksOrgan transplantation

Identifiers

PMID40533820
PMCPMC12175419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.